These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34416258)

  • 1. Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Viswanathan K; Sadow PM
    Hum Pathol; 2021 Nov; 117():88-100. PubMed ID: 34416258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
    Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
    Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
    Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
    Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases.
    Jannapureddy S; Cohen C; Lau S; Beitler JJ; Siddiqui MT
    Diagn Cytopathol; 2010 Nov; 38(11):795-800. PubMed ID: 20014308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
    Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
    Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.
    Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C
    Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.
    Jiang W; Chamberlain PD; Garden AS; Kim BY; Ma D; Lo EJ; Bell D; Gunn GB; Fuller CD; Rosenthal DI; Beadle BM; Frank SJ; Morrison WH; El-Naggar AK; Glisson BS; Sturgis EM; Phan J
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1459-66. PubMed ID: 26560893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
    Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
    Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
    Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
    Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
    Xue N; Lin JH; Xing S; Liu D; Li SB; Lai YZ; Wang XP; Mao MJ; Zhong Q; Zeng MS; Liu WL
    Cancer Res Treat; 2019 Jan; 51(1):378-390. PubMed ID: 29807404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and Epstein-Barr virus co-infection in oral and oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Rahman R; Shaikh MH; Gopinath D; Idris A; Johnson NW
    Mol Oral Microbiol; 2023 Aug; 38(4):259-274. PubMed ID: 37014754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
    Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
    BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
    Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
    Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonkeratinizing Nasopharyngeal Carcinoma, Undifferentiated Type With Trisomy 2: A Case Report and Short Review of Cytogenetic and Molecular Literature.
    Pontoriero F; Silverman AM; Pascasio JM; Bajaj R
    Pediatr Dev Pathol; 2020; 23(6):448-452. PubMed ID: 32755442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
    Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
    Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Human Papillomavirus and Co-Infection with Epstein-Barr Virus in Oral and Oropharyngeal Squamous Cell Carcinomas.
    Makvandi M; Jalilian S; Faghihloo E; Khanizadeh S; Ramezani A; Bagheri S; Mirzaei H
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3931-3937. PubMed ID: 36444607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.